Allarity Therapeutics Inc — Rendiconto Finanziario (NASDAQ:ALLR) | MetaTrader

Apri il grafico completo

Notizie

Allarity ottiene finanziamento di 20 milioni di dollari per estendere la liquidità

Allarity ottiene finanziamento di 20 milioni di dollari per estendere la propria liquidità

Allarity secures $20M debt financing to extend cash runway

First patients dosed in VA-funded stenoparib trial for lung cancer

Allarity avvia uno studio di fase 2 sulla combinazione di stenoparib per il cancro al polmone

Allarity begins phase 2 trial of stenoparib combination for lung cancer

Stenoparib shows promising survival data in ovarian cancer patients

Are Medical Stocks Lagging Boston Scientific (BSX) This Year?

Crude Oil Down 2%; US Durable Goods Orders Decline In July - Domo (NASDAQ:DOMO), Allarity Therapeutics (NASDAQ:ALLR)

US Stocks Mixed; American Woodmark Posts Downbeat Sales - American Woodmark (NASDAQ:AMWD), Allarity Therapeutics (NASDAQ:ALLR)

Allarity Therapeutics stock soars after FDA Fast Track designation

FDA grants fast track designation for Allarity’s ovarian cancer drug